NatureWise Biotech & Medicals Corporation 4732.TWO Stock
25 TWD
{{ price }}
-1.960784%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Taiwan
Exchange
Taipei Exchange
Market Cap
1.23B TWD
LOW - HIGH [24H]
24.3
-
25.25 TWD
VOLUME [24H]
80.06K TWD
{{ volume }}
P/E Ratio
75.75
Earnings per share
0.33 TWD
NatureWise Biotech & Medicals Corporation Price Chart
NatureWise Biotech & Medicals Corporation 4732.TWO Financial and Trading Overview
Contents
- NatureWise Biotech & Medicals Corporation Price Chart
- NatureWise Biotech & Medicals Corporation 4732.TWO Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of NatureWise Biotech & Medicals Corporation
- Q&A For NatureWise Biotech & Medicals Corporation Stock
| NatureWise Biotech & Medicals Corporation stock price | 25 TWD |
| Previous Close | 32.7 TWD |
| Open | 33.15 TWD |
| Bid | 31.85 TWD x 0 |
| Ask | 32.6 TWD x 0 |
| Day's Range | 31.85 - 33.25 TWD |
| 52 Week Range | 25.05 - 42.15 TWD |
| Volume | 15.16K TWD |
| Avg. Volume | 49.47K TWD |
| Market Cap | 1.59B TWD |
| Beta (5Y Monthly) | 0.659246 |
| PE Ratio (TTM) | 52.950817 |
| EPS (TTM) | 0.33 TWD |
| Forward Dividend & Yield | 0.3 (0.92%) |
| Ex-Dividend Date | August 19, 2022 |
| 1y Target Est | N/A |
4732.TWO Valuation Measures
| Enterprise Value | 1.14B TWD |
| Trailing P/E | 52.950817 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.964727 |
| Price/Book (mrq) | 2.4817517 |
| Enterprise Value/Revenue | 4.966 |
| Enterprise Value/EBITDA | 30.563 |
Trading Information
NatureWise Biotech & Medicals Corporation Stock Price History
| Beta (5Y Monthly) | 0.659246 |
| 52-Week Change | 10.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 42.15 TWD |
| 52 Week Low | 25.05 TWD |
| 50-Day Moving Average | 32.28 TWD |
| 200-Day Moving Average | 33.55 TWD |
4732.TWO Share Statistics
| Avg. Volume (3 month) | 49.47K TWD |
| Avg. Daily Volume (10-Days) | 67.86K TWD |
| Shares Outstanding | 49.29M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 1.52% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4918 |
| Last Split Factor | 1060:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 13.13% |
| Operating Margin (ttm) | 11.52% |
| Gross Margin | 56.83% |
| EBITDA Margin | 16.25% |
Management Effectiveness
| Return on Assets (ttm) | 2.35% |
| Return on Equity (ttm) | 4.74% |
Income Statement
| Revenue (ttm) | 228.59M TWD |
| Revenue Per Share (ttm) | 4.64 TWD |
| Quarterly Revenue Growth (yoy) | -36.00000000000000000000000000000000% |
| Gross Profit (ttm) | 129.93M TWD |
| EBITDA | 37.15M TWD |
| Net Income Avi to Common (ttm) | 30.02M TWD |
| Diluted EPS (ttm) | 0.61 |
| Quarterly Earnings Growth (yoy) | -72.20% |
Balance Sheet
| Total Cash (mrq) | 493.98M TWD |
| Total Cash Per Share (mrq) | 10.02 TWD |
| Total Debt (mrq) | 2.7M TWD |
| Total Debt/Equity (mrq) | 0.42 TWD |
| Current Ratio (mrq) | 14.523 |
| Book Value Per Share (mrq) | 13.015 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.85M TWD |
| Levered Free Cash Flow (ttm) | 569.88K TWD |
Profile of NatureWise Biotech & Medicals Corporation
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 36, Bade Road |
| ZIP | 105 |
| Phone | 886 2 2570 6300 |
| Website | https://www.naturewise.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.
Q&A For NatureWise Biotech & Medicals Corporation Stock
What is a current 4732.TWO stock price?
NatureWise Biotech & Medicals Corporation 4732.TWO stock price today per share is 25 TWD.
How to purchase NatureWise Biotech & Medicals Corporation stock?
You can buy 4732.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NatureWise Biotech & Medicals Corporation?
The stock symbol or ticker of NatureWise Biotech & Medicals Corporation is 4732.TWO.
Which industry does the NatureWise Biotech & Medicals Corporation company belong to?
The NatureWise Biotech & Medicals Corporation industry is Biotechnology.
How many shares does NatureWise Biotech & Medicals Corporation have in circulation?
The max supply of NatureWise Biotech & Medicals Corporation shares is 49.29M.
What is NatureWise Biotech & Medicals Corporation Price to Earnings Ratio (PE Ratio)?
NatureWise Biotech & Medicals Corporation PE Ratio is 75.75757600 now.
What was NatureWise Biotech & Medicals Corporation earnings per share over the trailing 12 months (TTM)?
NatureWise Biotech & Medicals Corporation EPS is 0.33 TWD over the trailing 12 months.
Which sector does the NatureWise Biotech & Medicals Corporation company belong to?
The NatureWise Biotech & Medicals Corporation sector is Healthcare.